PhD Candidate / Doctoral Researcher in Immunology (Project P06) | PhD (m/f/d) Project P06 - RTG 3095 "Protective and pathogeni

Universitätsklinikum Schleswig-Holstein

Kiel, Schleswig-Holstein, Deutschland
Published Nov 27, 2025
Full-time
Permanent

Job Summary

This position is for a PhD Candidate to join the DFG-funded Research Training Group (RTG) 3095, focusing on protective and pathogenic antibody responses at immunological barrier organs. The successful candidate will execute subproject P06 at Kiel University, investigating the mechanisms behind IgA+ B cell generation specifically in lung tissue. Day-to-day responsibilities include conducting advanced doctoral research, generating single-cell interactomes of murine B cells, and applying bioinformatics for high-throughput data analysis (e.g., scRNA-seq). Key requirements include a Master’s degree in Life Sciences, an excellent command of English, and motivation to use statistical software like R. This role is highly attractive due to its structured 4-year training program, strong international and interdisciplinary team environment, and access to cutting-edge technologies like single-cell sequencing and spatial transcriptomics, offering superb opportunities for scientific qualification in modern immunology.

Required Skills

Education

Master’s degree (or equivalent) in Life Sciences or a related discipline, fulfilling formal requirements for doctoral candidacy

Experience

  • Professional experience with mouse models (advantageous)
  • Professional experience with flow cytometry (advantageous)
  • Professional experience with molecular and cellular biology techniques (advantageous)
  • Experience applying bioinformatics approaches for the analysis of high-throughput datasets
  • Experience with R or comparable statistical software (desirable)

Languages

German (Basic)English (Fluent)

Additional

  • Fixed-term contract until March 31, 2030; Must fulfill formal requirements for enrolment as a doctoral candidate at the University of Lübeck; Start date April 1, 2026.